Screen for corona virus (COVID-19) in under 15 minutes with BB-Rapid through qualitative detection of IgM and IgG antibodies.

For more information please contact:

covid@bostonbiopharma.com

Latest updates on COVID-19
Find out how our easy tests are helping to fight the coronavirus

April 3, 2020

The Testing Debate for COVID-19: PCR vs. Rapid Antibody Test: How Rapid Antibody Testing can Identify Potential Immune Patients Quickly...

 

March 28, 2020

COVID-19 is spreading at a rapid pace throughout the United States and Western Europe. Fragmented strategies of banning travel, social distancing, and quarantine have provided little avail in slowing the steep upward trajectory of daily exponential growth rates...

March 25, 2020

WHO PRESS BRIEFING

Dr. Tedros Adhanom Ghebreyesus, Director-General of WHO, March 25, 2020 

Boston Biopharma

Boston Biopharma is a US-based pharmaceutical company that specializes in providing the highest quality specialty medications worldwide, especially emerging countries. We do this through pioneering R&D, and licensing, manufacturing, and commercializing the finest therapeutics especially oncology, multiple sclerosis, and immunology.

Boston Biopharma is headquartered in the United States with offices in Ukraine, Algeria, Malta, and Georgia. With a focus on product quality and operational flexibility, Boston Biopharma develops pharmaceutical products for sale in markets around the world. Our firm brings decades of healthcare industry expertise to some of the most difficult markets.

Strategy

LICENSING

Boston Biopharma has a growing list of products available for license in various markets.

EXPORT

From our US and EU-certified facilities, Boston Biopharma can produce and export our full range of products.

LOCALIZATION

Boston Biopharma has partnered with qualified individuals and businesses in emerging economies to bring our expertise to local markets.